Contribution of human muscle-derived cells to skeletal muscle regeneration in dystrophic host mice

PLoS ONE

Volumn 6, Issue 3, 2011, Pages

  Meng, Jinhong ^a   Adkin, Carl F ^a   Xu, Shi wen ^b   Muntoni, Francesco ^a   Morgan, Jennifer E ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BROXURIDINE; CD56 ANTIGEN; BIOLOGICAL MARKER;

ADOLESCENT; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL DIFFERENTIATION; CELL ISOLATION; CHILD; CLINICAL ARTICLE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; HUMAN MUSCLE DERIVED CELL; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; MOUSE; MUSCLE BIOPSY; MUSCLE CELL; MUSCLE DEVELOPMENT; MUSCLE REGENERATION; MUSCULAR DYSTROPHY; MYOTUBE; NONHUMAN; OUTCOME ASSESSMENT; PERICYTE; PHENOTYPE; PRESCHOOL CHILD; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SCHOOL CHILD; SYSTEMIC DISEASE; ANIMAL; ANIMAL MUSCULAR DYSTROPHY; CELL AGING; CELL PROLIFERATION; CYTOLOGY; FEMALE; GENETICS; INTRAARTERIAL DRUG ADMINISTRATION; MALE; MESENCHYMAL STEM CELL; METABOLISM; MYOBLAST; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; REGENERATION; SKELETAL MUSCLE; TIME; TRANSPLANTATION; X CHROMOSOME LINKED MUSCULAR DYSTROPHIC MOUSE;

ANIMALIA; MUS;

ADOLESCENT; ANIMALS; ANTIGENS, CD56; BIOLOGICAL MARKERS; CELL AGING; CELL PROLIFERATION; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; INJECTIONS, INTRA-ARTERIAL; MALE; MESENCHYMAL STEM CELLS; MICE; MICE, INBRED MDX; MUSCLE CELLS; MUSCLE DEVELOPMENT; MUSCLE, SKELETAL; MUSCULAR DYSTROPHY, ANIMAL; MYOBLASTS; PERICYTES; REGENERATION; TIME FACTORS;

EID: 79952409050     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0017454     Document Type: Article

References (64)

1. Grounds MD, Davies KE, (2007) The allure of stem cell therapy for muscular dystrophy. Neuromuscul Disord 17: 206-208.
2. Hoffman EP, Brown RH Jr, Kunkel LM, (1987) Dystrophin: the protein product of the Duchenne muscular dystrophy locus. Cell 51: 919-928.
3. Hoffman EP, Fischbeck KH, Brown RH, Johnson M, Medori R, et al. (1988) Characterization of dystrophin in muscle-biopsy specimens from patients with Duchenne's or Becker's muscular dystrophy. N Engl J Med 318: 1363-1368.
4. Peault B, Rudnicki M, Torrente Y, Cossu G, Tremblay JP, et al. (2007) Stem and progenitor cells in skeletal muscle development, maintenance, and therapy. Mol Ther 15: 867-877.
5. Collins CA, Olsen I, Zammit PS, Heslop L, Petrie A, et al. (2005) Stem cell function, self-renewal, and behavioral heterogeneity of cells from the adult muscle satellite cell niche. Cell 122: 289-301.
6. Partridge TA, Morgan JE, Coulton GR, Hoffman EP, Kunkel LM, (1989) Conversion of mdx myofibres from dystrophin-negative to-positive by injection of normal myoblasts. Nature 337: 176-179.
7. Law PK, Goodwin TG, Fang Q, Duggirala V, Larkin C, et al. (1992) Feasibility, safety, and efficacy of myoblast transfer therapy on Duchenne muscular dystrophy boys. Cell Transplant 1: 235-244.
8. Tremblay JP, Malouin F, Roy R, Huard J, Bouchard JP, et al. (1993) Results of a triple blind clinical study of myoblast transplantations without immunosuppressive treatment in young boys with Duchenne muscular dystrophy. Cell Transplant 2: 99-112.
9. Mendell JR, (1990) Immunosuppressive therapy in Duchenne muscular dystrophy: considerations for myoblast transfer studies. Adv Exp Med Biol 280: 287-295.
10. Mendell JR, Kissel JT, Amato AA, King W, Signore L, et al. (1995) Myoblast transfer in the treatment of Duchenne's muscular dystrophy. N Engl J Med 333: 832-838.
11. Benchaouir R, Meregalli M, Farini A, D'Antona G, Belicchi M, et al. (2007) Restoration of human dystrophin following transplantation of exon-skipping-engineered DMD patient stem cells into dystrophic mice. Cell Stem Cell 1: 646-657.
12. De BC, Dell'Accio F, Vandenabeele F, Vermeesch JR, Raymackers JM, et al. (2003) Skeletal muscle repair by adult human mesenchymal stem cells from synovial membrane. J Cell Biol 160: 909-918.
13. Dellavalle A, Sampaolesi M, Tonlorenzi R, Tagliafico E, Sacchetti B, et al. (2007) Pericytes of human skeletal muscle are myogenic precursors distinct from satellite cells. Nat Cell Biol 9: 255-267.
14. Chan J, O'Donoghue K, Gavina M, Torrente Y, Kennea N, et al. (2006) Galectin-1 induces skeletal muscle differentiation in human fetal mesenchymal stem cells and increases muscle regeneration. Stem Cells 24: 1879-1891.
15. Chan J, Waddington SN, O'Donoghue K, Kurata H, Guillot PV, et al. (2007) Widespread distribution and muscle differentiation of human fetal mesenchymal stem cells after intrauterine transplantation in dystrophic mdx mouse. Stem Cells 25: 875-884.
16. Gang EJ, Jeong JA, Hong SH, Hwang SH, Kim SW, et al. (2004) Skeletal myogenic differentiation of mesenchymal stem cells isolated from human umbilical cord blood. Stem Cells 22: 617-624.
17. Morosetti R, Mirabella M, Gliubizzi C, Broccolini A, De Angelis L, et al. (2006) MyoD expression restores defective myogenic differentiation of human mesoangioblasts from inclusion-body myositis muscle. Proc Natl Acad Sci U S A 103: 16995-17000.
18. Morosetti R, Mirabella M, Gliubizzi C, Broccolini A, Sancricca C, et al. (2007) Isolation and characterization of mesoangioblasts from facioscapulohumeral muscular dystrophy muscle biopsies. Stem Cells 25: 3173-3182.
19. Sampaolesi M, Blot S, D'Antona G, Granger N, Tonlorenzi R, et al. (2006) Mesoangioblast stem cells ameliorate muscle function in dystrophic dogs. Nature 444: 574-579.
20. Sampaolesi M, Torrente Y, Innocenzi A, Tonlorenzi R, D'Antona G, et al. (2003) Cell therapy of alpha-sarcoglycan null dystrophic mice through intra-arterial delivery of mesoangioblasts. Science 301: 487-492.
21. Tonlorenzi R, Dellavalle A, Schnapp E, Cossu G, Sampaolesi M, (2007) Isolation and characterization of mesoangioblasts from mouse, dog, and human tissues. Curr Protoc Stem Cell Biol Chapter 2: Unit.
22. Meng J, Adkin CF, rechavala-Gomeza V, Boldrin L, Muntoni F, et al. (2010) The contribution of human synovial stem cells to skeletal muscle regeneration. Neuromuscul Disord 20: 6-15.
23. Brimah K, Ehrhardt J, Mouly V, Butler-Browne GS, Partridge TA, et al. (2004) Human muscle precursor cell regeneration in the mouse host is enhanced by growth factors. Hum Gene Ther 15: 1109-1124.
24. Ehrhardt J, Brimah K, Adkin C, Partridge T, Morgan J, (2007) Human muscle precursor cells give rise to functional satellite cells in vivo. Neuromuscul Disord 17: 631-638.
25. Collins CA, (2006) Satellite cell self-renewal. Curr Opin Pharmacol 6: 301-306.
26. Ieronimakis N, Balasundaram G, Rainey S, Srirangam K, Yablonka-Reuveni Z, et al. (2010) Absence of CD34 on murine skeletal muscle satellite cells marks a reversible state of activation during acute injury. PLoS ONE 5: e10920.
27. Allegra A, Coppolino G, Bolignano D, Giacobbe MS, Alonci A, et al. (2009) Endothelial progenitor cells: pathogenetic role and therapeutic perspectives. J Nephrol 22: 463-475.
28. Nielsen JS, McNagny KM, (2009) CD34 is a key regulator of hematopoietic stem cell trafficking to bone marrow and mast cell progenitor trafficking in the periphery. Microcirculation 16: 487-496.
29. Mastrandrea F, Semeraro FP, Coradduzza G, Manelli M, Scarcia G, et al. (2008) CD34+ hemopoietic precursor and stem cells traffic in peripheral blood of celiac patients is significantly increased but not directly related to epithelial damage severity. Eur Ann Allergy Clin Immunol 40: 90-103.
30. Zheng B, Cao B, Crisan M, Sun B, Li G, et al. (2007) Prospective identification of myogenic endothelial cells in human skeletal muscle. Nat Biotechnol 25: 1025-1034.
31. Pittenger MF, Mackay AM, Beck SC, Jaiswal RK, Douglas R, et al. (1999) Multilineage potential of adult human mesenchymal stem cells. Science 284: 143-147.
32. Kemp KC, Hows J, Donaldson C, (2005) Bone marrow-derived mesenchymal stem cells. Leuk Lymphoma 46: 1531-1544.
33. Quinlan JG, Cambier D, Lyden S, Dalvi A, Upputuri RK, et al. (1997) Regeneration-blocked mdx muscle: in vivo model for testing treatments. Muscle Nerve 20: 1016-1023.
34. Wakeford S, Watt DJ, Partridge TA, (1991) X-irradiation improves mdx mouse muscle as a model of myofiber loss in DMD. Muscle Nerve 14: 42-50.
35. Ramalho-Santos M, Willenbring H, (2007) On the origin of the term "stem cell". Cell Stem Cell 1: 35-38.
36. Cossu G, Bianco P, (2003) Mesoangioblasts-vascular progenitors for extravascular mesodermal tissues. Curr Opin Genet Dev 13: 537-542.
37. Chen CW, Montelatici E, Crisan M, Corselli M, Huard J, et al. (2009) Perivascular multi-lineage progenitor cells in human organs: regenerative units, cytokine sources or both? Cytokine Growth Factor Rev 20: 429-434.
38. Asakura A, Seale P, Girgis-Gabardo A, Rudnicki MA, (2002) Myogenic specification of side population cells in skeletal muscle. J Cell Biol 159: 123-134.
39. Uezumi A, Ojima K, Fukada S, Ikemoto M, Masuda S, et al. (2006) Functional heterogeneity of side population cells in skeletal muscle. Biochem Biophys Res Commun 341: 864-873.
40. Huard J, Cao B, Qu-Petersen Z, (2003) Muscle-derived stem cells: potential for muscle regeneration. Birth Defects Res C Embryo Today 69: 230-237.
41. Qu-Petersen Z, Deasy B, Jankowski R, Ikezawa M, Cummins J, et al. (2002) Identification of a novel population of muscle stem cells in mice: potential for muscle regeneration. J Cell Biol 157: 851-864.
42. Tamaki T, Uchiyama Y, Okada Y, Ishikawa T, Sato M, et al. (2005) Functional recovery of damaged skeletal muscle through synchronized vasculogenesis, myogenesis, and neurogenesis by muscle-derived stem cells. Circulation 112: 2857-2866.
43. Tamaki T, Akatsuka A, Ando K, Nakamura Y, Matsuzawa H, et al. (2002) Identification of myogenic-endothelial progenitor cells in the interstitial spaces of skeletal muscle. J Cell Biol 157: 571-577.
44. Mitchell KJ, Pannerec A, Cadot B, Parlakian A, Besson V, et al. (2010) Identification and characterization of a non-satellite cell muscle resident progenitor during postnatal development. Nat Cell Biol 12: 257-266.
45. Conboy IM, Rando TA, (2005) Aging, stem cells and tissue regeneration: lessons from muscle. Cell Cycle 4: 407-410.
46. Carlson ME, Conboy IM, (2007) Loss of stem cell regenerative capacity within aged niches. Aging Cell 6: 371-382.
47. Deasy BM, Lu A, Tebbets JC, Feduska JM, Schugar RC, et al. (2007) A role for cell sex in stem cell-mediated skeletal muscle regeneration: female cells have higher muscle regeneration efficiency. J Cell Biol 177: 73-86.
48. Eberli D, Soker S, Atala A, Yoo JJ, (2009) Optimization of human skeletal muscle precursor cell culture and myofiber formation in vitro. Methods 47: 98-103.
49. Abuzakouk M, Feighery C, O'Farrelly C, (1996) Collagenase and Dispase enzymes disrupt lymphocyte surface molecules. J Immunol Methods 194: 211-216.
50. Cao B, Huard J, (2004) Muscle-derived stem cells. Cell Cycle 3: 104-107.
51. Jankowski RJ, Haluszczak C, Trucco M, Huard J, (2001) Flow cytometric characterization of myogenic cell populations obtained via the preplate technique: potential for rapid isolation of muscle-derived stem cells. Hum Gene Ther 12: 619-628.
52. Lecourt S, Marolleau JP, Fromigue O, Vauchez K, Andriamanalijaona R, et al. (2010) Characterization of distinct mesenchymal-like cell populations from human skeletal muscle in situ and in vitro. Exp Cell Res 10; 316 (15): 2513-26.
53. Pisani DF, Dechesne CA, Sacconi S, Delplace S, Belmonte N, et al. (2010) Isolation of a highly myogenic CD34-negative subset of human skeletal muscle cells free of adipogenic potential. Stem Cells 28: 753-764.
54. Vauchez K, Marolleau JP, Schmid M, Khattar P, Chapel A, et al. (2009) Aldehyde dehydrogenase activity identifies a population of human skeletal muscle cells with high myogenic capacities. Mol Ther 17: 1948-1958.
55. Montarras D, Morgan J, Collins C, Relaix F, Zaffran S, et al. (2005) Direct isolation of satellite cells for skeletal muscle regeneration. Science 309: 2064-2067.
56. Kinali M, rechavala-Gomeza V, Feng L, Cirak S, Hunt D, et al. (2009) Local restoration of dystrophin expression with the morpholino oligomer AVI-4658 in Duchenne muscular dystrophy: a single-blind, placebo-controlled, dose-escalation, proof-of-concept study. Lancet Neurol 8: 918-928.
57. Belles-Isles M, Roy R, Dansereau G, Goulet M, Roy B, et al. (1993) Rapid selection of donor myoblast clones for muscular dystrophy therapy using cell surface expression of NCAM. Eur J Histochem 37: 375-380.
58. Ditlevsen DK, Povlsen GK, Berezin V, Bock E, (2008) NCAM-induced intracellular signaling revisited. J Neurosci Res 86: 727-743.
59. Fidzianska A, Kaminska A, (1995) Neural cell adhesion molecule (N-CAM) as a marker of muscle tissue alternations. Review of the literature and own observations. Folia Neuropathol 33: 125-128.
60. Moretta A, Ciccone E, Tambussi G, Bottino C, Viale O, et al. (1989) Surface molecules involved in CD3-negative NK cell function. A novel molecule which regulates the activation of a subset of human NK cells. Int J Cancer Suppl 4 pp. 48-52.
61. Bosma MJ, Carroll AM, (1991) The SCID mouse mutant: definition, characterization, and potential uses. Annu Rev Immunol 9: 323-350.
62. Cooper RN, Irintchev A, Di Santo JP, Zweyer M, Morgan JE, et al. (2001) A new immunodeficient mouse model for human myoblast transplantation. Hum Gene Ther 12: 823-831.
63. Silva-Barbosa SD, Butler-Browne GS, Di Santo JP, Mouly V, (2005) Comparative analysis of genetically engineered immunodeficient mouse strains as recipients for human myoblast transplantation. Cell Transplant 14: 457-467.
64. Fukada S, Morikawa D, Yamamoto Y, Yoshida T, Sumie N, et al. (2010) Genetic background affects properties of satellite cells and mdx phenotypes. Am J Pathol 176: 2414-2424.